Dermata Therapeutics, Inc.
DRMAAnalyst Consensus
Price Target Trend
Rating Trend
Recent Price Targets
| Date | Firm | Analyst | Target | Price Then | Source |
|---|---|---|---|---|---|
| Aug 21, 2024 | Maxim Group | Anthony Vendetti | $6.00(+191%) | $2.06 | StreetInsider |
Recent Rating Actions
| Firm | Action | Rating | Date |
|---|---|---|---|
| Maxim Group | maintain | Buy | Aug 21, 2025 |
| Maxim Group | maintain | Buy | May 21, 2025 |
| Maxim Group | maintain | Buy | Aug 21, 2024 |
| Maxim Group | maintain | Buy | Mar 23, 2023 |
Earnings History
Next report: Nov 18, 2026 · EPS est. $-0.55| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 11, 2026 | $-0.74 | $-0.55 | — | — |
| May 13, 2026 | $-0.48 | $-0.53 | — | — |
| Mar 26, 2026 | $-1.52 | $-1.54 | — | — |
| Nov 14, 2025 | $-1.65 | $-1.59 | — | — |
| Aug 13, 2025 | $-1.66 | $-2.90 | — | — |
| May 14, 2025 | $-4.50 | $-4.50 | — | — |
| Mar 17, 2025 | $-13.40 | $-15.00 | — | — |
| Nov 13, 2024 | $-20.40 | $-26.40 | — | — |
News
- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments - - Over 71% of study participants were graded as having overall improvements in their skin after only one treatment - - Tome Foundational Treatment is designed to renew the appearance of skin and improve tone and texture over time - SAN DIEGO, CA / ACCESS Newswire / October 15, 2026 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-dr…
- Tome Foundational Treatment, powered by Bioneedle™, is now available for purchase at www.tomeskincare.com - - Once-weekly Foundational Treatment is designed to renew the appearance of skin and improve tone and texture over time - - Consumers can purchase a one-month kit or subscribe for convenient recurring delivery - SAN DIEGO, CA / ACCESS Newswire / August 25, 2026 / Dermata Therapeutics, Inc. (Nasdaq:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, tod…
- Preorders can be made by visiting www.tomeskincare.com - - Dermata is ready to begin shipping orders on the expected launch date of August 25, 2026 - - Tome Foundational Treatment is a once-weekly topical mask for skin renewal - SAN DIEGO, CA / ACCESS Newswire / August 21, 2026 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced that Tome Foundational Treatment, the Company's first direct-to-consumer skinca…
$3.4 million upfront with up to approximately $6.7 million of potential additional gross proceeds upon the exercise in full of warrants SAN DIEGO, CA / ACCESS Newswire / August 17, 2026 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2,293,608 shares of common stock (or pre-funded warrants in lieu thereof), series…
- Dermata announced the launch date of its first commercial product, Tome™ Foundational Treatment, expected on August 25, 2026 - - Dermata recently attended Be+Well Beauty and Wellness Show in Las Vegas, NV to announce the Tome brand - SAN DIEGO, CA / ACCESS Newswire / August 11, 2026 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today highlighted recent corporate progress and reported financial results for the second…